CY2019042I1 - Οφθαλμολογικες συνθεσεις και η χρηση τους - Google Patents

Οφθαλμολογικες συνθεσεις και η χρηση τους

Info

Publication number
CY2019042I1
CY2019042I1 CY2019042C CY2019042C CY2019042I1 CY 2019042 I1 CY2019042 I1 CY 2019042I1 CY 2019042 C CY2019042 C CY 2019042C CY 2019042 C CY2019042 C CY 2019042C CY 2019042 I1 CY2019042 I1 CY 2019042I1
Authority
CY
Cyprus
Prior art keywords
ophthalmic compositions
ophthalmic
compositions
Prior art date
Application number
CY2019042C
Other languages
English (en)
Other versions
CY2019042I2 (el
Original Assignee
Laboratoires Thea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Thea filed Critical Laboratoires Thea
Publication of CY2019042I2 publication Critical patent/CY2019042I2/el
Publication of CY2019042I1 publication Critical patent/CY2019042I1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CY2019042C 2005-03-09 2019-11-05 Οφθαλμολογικες συνθεσεις και η χρηση τους CY2019042I1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502357A FR2882930B1 (fr) 2005-03-09 2005-03-09 Nouvelles compositions ophtalmologiques et leur mode d'utilisation
PCT/FR2006/000528 WO2006095095A1 (fr) 2005-03-09 2006-03-09 Compositions ophtalmologiques et leur mode d’utilisation

Publications (2)

Publication Number Publication Date
CY2019042I2 CY2019042I2 (el) 2020-05-29
CY2019042I1 true CY2019042I1 (el) 2020-05-29

Family

ID=35058756

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20191100828T CY1121865T1 (el) 2005-03-09 2019-08-05 Οφθαλμολογικες συνθεσεις και η χρηση τους
CY2019042C CY2019042I1 (el) 2005-03-09 2019-11-05 Οφθαλμολογικες συνθεσεις και η χρηση τους

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20191100828T CY1121865T1 (el) 2005-03-09 2019-08-05 Οφθαλμολογικες συνθεσεις και η χρηση τους

Country Status (26)

Country Link
US (2) US20080194649A1 (el)
EP (1) EP1858481B1 (el)
JP (1) JP2008532985A (el)
KR (1) KR20070111501A (el)
CN (1) CN101151018A (el)
CA (1) CA2598503C (el)
CY (2) CY1121865T1 (el)
DK (1) DK1858481T3 (el)
ES (1) ES2728071T3 (el)
FR (1) FR2882930B1 (el)
HR (1) HRP20191044T1 (el)
HU (1) HUE043668T2 (el)
IL (1) IL185197A0 (el)
LT (2) LT1858481T (el)
LU (1) LUC00136I2 (el)
MA (1) MA29269B1 (el)
MX (1) MX2007010295A (el)
NL (1) NL301017I2 (el)
NO (2) NO339793B1 (el)
PL (1) PL1858481T3 (el)
PT (1) PT1858481T (el)
RU (1) RU2392925C2 (el)
SI (1) SI1858481T1 (el)
TN (1) TNSN07343A1 (el)
TR (1) TR201908487T4 (el)
WO (1) WO2006095095A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8602959B1 (en) * 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
EP2675455A4 (en) * 2011-02-18 2014-07-16 M S Appasamy Associates OPHTHALMIC COMPOSITION FOR DILATING PUPILS
ITPA20110004A1 (it) * 2011-02-23 2012-08-24 Francesco Paolo Montalto Iniezione intracamerulare per anestesia e dilatazione pupillare (midriasi).
CN103159672A (zh) * 2012-07-16 2013-06-19 湖南尔文生物科技有限公司 一种托品酰胺的制备方法
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
RU2525512C1 (ru) * 2013-03-28 2014-08-20 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ медикаментозного расширения ригидного зрачка перед проведением факоэмульсификации
MX2016004257A (es) * 2013-10-03 2016-08-17 Imprimis Pharmaceuticals Inc Composiciones oftalmicas basadas en epinefrina para la administracion intraocular y metodos para su frabricacion.
CN105213418B (zh) * 2015-11-11 2019-01-22 中国人民解放军第四军医大学 一种眼科术前用复方滴眼液及其制备方法
JP2019524896A (ja) 2016-08-25 2019-09-05 ハーロウ・ヘルス・インコーポレイテッドHarrow Health, Inc. 眼内投与のためのエピネフリンベースの眼科組成物及びその製造方法
RU2649534C1 (ru) * 2017-05-10 2018-04-03 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ анестезии при факоэмульсификации катаракты
RU2662423C1 (ru) * 2017-07-26 2018-07-25 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ проведения обезболивания при выполнении витреоретинальных операций

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026323A (en) * 1960-03-22 1962-03-20 Rubin J Schacter Salts of tribasic acids
JPH0780760B2 (ja) * 1986-07-28 1995-08-30 ライオン株式会社 安定化されたフエニレフリン系液剤
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
US5779661A (en) * 1995-12-11 1998-07-14 Physion, S.R.L. Method of treating dysfunctional bladder syndromes by electromotive drug administration
US6319240B1 (en) * 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
CA2391448A1 (en) * 1999-11-12 2001-05-17 Leo Rubin Use of vasoactive intestinal peptides and kits therefor
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
JP4150846B2 (ja) * 2001-03-28 2008-09-17 参天製薬株式会社 ステロイドを有効成分とする網脈絡膜疾患治療剤
US20040013729A1 (en) * 2002-07-18 2004-01-22 Buono Lawrence M. Single-drop multiple-agent composition for topical delivery to the eye
AU2003261304A1 (en) * 2002-07-30 2004-02-16 Omeros Corporation Ophthalmologic irrigation solutions and method

Also Published As

Publication number Publication date
BRPI0607416A2 (pt) 2009-09-08
IL185197A0 (en) 2008-01-06
HUE043668T2 (hu) 2019-08-28
CN101151018A (zh) 2008-03-26
MX2007010295A (es) 2007-12-11
RU2392925C2 (ru) 2010-06-27
LUC00136I1 (el) 2019-11-04
US20120220637A1 (en) 2012-08-30
FR2882930A1 (fr) 2006-09-15
SI1858481T1 (sl) 2019-08-30
FR2882930B1 (fr) 2009-03-27
CA2598503A1 (fr) 2006-09-14
NL301017I2 (nl) 2020-04-30
CY2019042I2 (el) 2020-05-29
NL301017I1 (nl) 2019-11-06
NO339793B1 (no) 2017-01-30
TR201908487T4 (tr) 2019-07-22
MA29269B1 (fr) 2008-02-01
HRP20191044T1 (hr) 2019-09-06
JP2008532985A (ja) 2008-08-21
WO2006095095A1 (fr) 2006-09-14
PT1858481T (pt) 2019-06-14
ES2728071T3 (es) 2019-10-22
NO20074850L (no) 2007-09-24
NO2017008I1 (no) 2017-03-24
CY1121865T1 (el) 2020-05-29
LT1858481T (lt) 2019-07-10
LUC00136I2 (el) 2021-02-12
TNSN07343A1 (fr) 2008-12-31
EP1858481B1 (fr) 2019-05-08
NO2017008I2 (no) 2017-03-24
CA2598503C (fr) 2014-01-28
PL1858481T3 (pl) 2019-09-30
US20080194649A1 (en) 2008-08-14
KR20070111501A (ko) 2007-11-21
DK1858481T3 (da) 2019-06-03
US9289399B2 (en) 2016-03-22
RU2007137115A (ru) 2009-04-20
LTPA2019017I1 (lt) 2019-12-10
EP1858481A1 (fr) 2007-11-28

Similar Documents

Publication Publication Date Title
CY2019042I1 (el) Οφθαλμολογικες συνθεσεις και η χρηση τους
CY2017006I1 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK1811959T4 (da) Oftalmiske sammensætninger
DK3295967T3 (da) Sårplejeindretning
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
CY2015013I1 (el) Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων
BRPI0613033A2 (pt) composição oral
DE602006008034D1 (de) Intraokularer shunt
DE602005008726D1 (de) Verwendet
NO20055686D0 (no) Sammensetning
ATE510595T1 (de) Haarbehandlungszusammensetzungen
DE602006006937D1 (de) Hosenträger
DE602006021210D1 (de) Haarbehandlungszusammensetzungen
FR2881342B1 (fr) Composition demaquillante
DE602006011271D1 (de) Anthelminthische zusammensetzung
DE602006007774D1 (de) Zahnreinigungsmittel
FR2885520B1 (fr) Composition cosmetique
FR2885521B1 (fr) Composition cosmetique
DE112006002272T8 (de) Katheter und Katheter-Kit
BRPI0620820A2 (pt) dentifrício
BRPI0620807A2 (pt) dentifrício
ITBO20050375A1 (it) Riunito dentale
ITMI20051658A1 (it) Composizioni cosmetiche
FR2890858B1 (fr) Composition demaquillante